share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

周二盘后交易时段，12只医疗保健股走势
Benzinga Real-time News ·  2023/02/07 16:33

Gainers

获胜者

  • SenesTech (NASDAQ:SNES) shares moved upwards by 11.1% to $4.11 during Tuesday's after-market session. SenesTech's trading volume hit 206.4K shares by close, accounting for 177.0% of its average volume over the last 100 days. The company's market cap stands at $2.7 million.
  • Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 6.71% to $0.59. The market value of their outstanding shares is at $8.9 million.
  • Aspira Womens Health (NASDAQ:AWH) shares moved upwards by 5.26% to $0.6. The company's market cap stands at $74.7 million.
  • Predictive Oncology (NASDAQ:POAI) shares moved upwards by 4.99% to $0.58. The company's market cap stands at $45.4 million.
  • Dyne Therapeutics (NASDAQ:DYN) shares moved upwards by 4.98% to $14.75. Dyne Therapeutics's trading volume hit 216.7K shares by close, accounting for 70.8% of its average volume over the last 100 days. The company's market cap stands at $768.8 million.
  • Immix Biopharma (NASDAQ:IMMX) shares rose 4.87% to $3.01. The company's market cap stands at $41.9 million.
  • SenesTech 纳斯达克股票代码：SNES）的股价在周二的盘后交易时段上涨了11.1％，至4.11美元。SenesTech的交易量收盘时达到20.64万股，占其过去100天平均交易量的177.0％。该公司的市值为270万美元。
  • 优尼赛夫疗法 纳斯达克股票代码：UNCY）的股价上涨了6.71％，至0.59美元。他们已发行股票的市值为890万美元。
  • Aspira 女性健康 纳斯达克股票代码：AWH）的股价上涨了5.26％，至0.6美元。该公司的市值为7,470万美元。
  • 预测性肿瘤学 纳斯达克股票代码：POAI）的股价上涨了4.99％，至0.58美元。该公司的市值为4540万美元。
  • 达因疗法 纳斯达克股票代码：DYN）的股价上涨了4.98％，至14.75美元。截至收盘，Dyne Therapeutics的交易量达到21.67万股，占其过去100天平均交易量的70.8％。该公司的市值为7.688亿美元。
  • Immix Biophar 纳斯达克股票代码：IMMX）股价上涨4.87％，至3.01美元。该公司的市值为4190万美元。

Losers

失败者

  • Lixte Biotech Hldgs (NASDAQ:LIXT) shares fell 10.6% to $1.69 during Tuesday's after-market session. Trading volume for this security closed at 1.0 million, accounting for 2183.3% of its average full-day volume over the last 100 days. The company's market cap stands at $28.1 million.
  • Evolus (NASDAQ:EOLS) stock decreased by 8.11% to $8.5. The market value of their outstanding shares is at $478.0 million.
  • Celyad Oncology (NASDAQ:CYAD) stock declined by 8.01% to $1.38. At the close, Celyad Oncology's trading volume reached 3.0 million shares. This is 210.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock declined by 7.49% to $2.1. This security traded at a volume of 98.1K shares come close, making up 17.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $19.9 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) stock fell 7.27% to $0.43. The company's market cap stands at $38.5 million.
  • Processa Pharma (NASDAQ:PCSA) stock declined by 7.08% to $0.81. The company's market cap stands at $12.9 million. See Also:
  • Lixte Biotech控股公司 纳斯达克股票代码：LIXT）股价在周二的盘后交易时段下跌10.6％，至1.69美元。该证券的交易量收于100万，占其过去100天平均全日交易量的2183.3％。该公司的市值为2810万美元。
  • Evolus 纳斯达克股票代码：EOLS）股价下跌8.11％，至8.5美元。他们已发行股票的市值为4.78亿美元。
  • Celyad 肿瘤学 纳斯达克股票代码：CYAD）股价下跌8.01％，至1.38美元。收盘时，Celyad Oncology的交易量达到300万股。这是其过去 100 天平均交易量的210.5％。他们已发行股票的市值为3,110万美元。
  • 有氧诊断控股公司 纳斯达克股票代码：CDIO）股价下跌7.49％，至2.1美元。该证券的交易量接近98.1万股，占其过去100天平均交易量的17.1％。他们已发行股票的市值为1,990万美元。
  • Nymox 制药 纳斯达克股票代码：NYMX）股价下跌7.27％，至0.43美元。该公司的市值为3,850万美元。
  • 过程制药 纳斯达克股票代码：PCSA）股价下跌7.08％，至0.81美元。该公司的市值为1,290万美元。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发